IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GRANDE, VERA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.864
NA - Nord America 1.843
AS - Asia 1.466
SA - Sud America 117
AF - Africa 53
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.351
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.819
GB - Regno Unito 1.485
CN - Cina 614
SG - Singapore 387
DE - Germania 283
IT - Italia 264
SE - Svezia 205
RU - Federazione Russa 148
HK - Hong Kong 147
FR - Francia 144
UA - Ucraina 120
IN - India 86
BR - Brasile 71
NL - Olanda 67
KR - Corea 64
EU - Europa 53
FI - Finlandia 53
TR - Turchia 51
CI - Costa d'Avorio 44
IE - Irlanda 37
VN - Vietnam 37
CO - Colombia 29
JP - Giappone 26
CA - Canada 17
ID - Indonesia 17
BE - Belgio 15
GR - Grecia 10
DK - Danimarca 8
BD - Bangladesh 7
TW - Taiwan 6
AR - Argentina 5
AU - Australia 5
EC - Ecuador 5
PL - Polonia 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
ES - Italia 4
SA - Arabia Saudita 4
CZ - Repubblica Ceca 3
IQ - Iraq 3
UY - Uruguay 3
CH - Svizzera 2
LU - Lussemburgo 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PK - Pakistan 2
PT - Portogallo 2
RO - Romania 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CL - Cile 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GT - Guatemala 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.403
Salva come PNG Salva come JPEG
Città #
Southend 1.382
Singapore 191
Ashburn 174
Milan 146
Hong Kong 141
Chandler 129
Beijing 128
Seattle 111
Jacksonville 96
Santa Clara 80
Dallas 79
Ann Arbor 70
Wilmington 70
Berlin 64
Princeton 60
San Jose 58
Woodbridge 56
Dearborn 55
Fairfield 54
Los Angeles 46
Abidjan 44
Bengaluru 40
Mountain View 39
Nanjing 39
Council Bluffs 38
Dublin 37
Redmond 37
Jinan 35
Serra 33
Houston 31
Bogotá 28
Helsinki 26
Andover 25
Sakarya 25
Boardman 24
Shanghai 24
Shenyang 24
Buffalo 20
Hefei 20
Medford 20
Phoenix 20
Scranton 20
Moscow 19
Tianjin 19
Somerville 18
Cambridge 17
Des Moines 17
Ningbo 17
Guangzhou 16
Hangzhou 16
Seoul 16
Brussels 15
Frankfurt am Main 15
Ho Chi Minh City 15
Nanchang 14
The Dalles 14
Toronto 14
Changsha 12
Columbus 12
Bühl 11
Jakarta 11
Kiez 11
Saint Petersburg 11
Athens 10
Hanoi 10
Hebei 10
Redwood City 9
Tokyo 9
Auburn Hills 8
San Diego 8
Cangzhou 7
Falls Church 7
Lansing 7
Shenzhen 7
Verona 7
Brooklyn 6
Chicago 6
Cincinnati 6
Kunming 6
Lauterbourg 6
New York 6
Nürnberg 6
Quanzhou 6
Eitensheim 5
Fuzhou 5
Madison 5
Bergamo 4
Bitonto 4
Bloomsbury 4
Denver 4
Detroit 4
Eygelshoven 4
Foshan 4
Hamburg 4
Jiaxing 4
Johannesburg 4
Lanzhou 4
Mumbai 4
Silver Spring 4
São Paulo 4
Totale 4.367
Salva come PNG Salva come JPEG
Nome #
Anti-EGFR Antibody Efficiently and Specifically Inhibits Human TSC2-/- Smooth Muscle Cell Proliferation. Possible Treatment Options for TSC and LAM 450
G protein-mediated signal transduction is affected in primary biliary cirrhosis 352
Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma : epidermal growth factor is the required growth factor 312
Expression of the anti-apoptotic protein survivin amd altered function of IGF-1 pathway in TSC2 brain tubers 276
Characterization of LAM/TSC cells isolated from patient chylous 264
Exploring the role of MKK7 in excitotoxicity and cerebral ischemia : a novel pharmacological strategy against brain injury 256
Development of a LAM model by using human TSC2-/- cells derived from a renal angiomyolipoma : A pharmacological evaluation 252
Survivin expression in tuberous sclerosis complex cells 251
A mouse LAM model by endonasal administration of human TSC2 deficient smooth muscle cells 251
Pathogenesis and pharmacological evaluation of human TSC2 smooth muscle cells. Possible treatment options for TSC and lymphangioleiomyomatosis 249
Human smooth muscle TSC2-/- cells cause lymphangiogenesis-like lung destruction in nude mice. Pharmacological repair 248
Farmacologia 247
Un modello di linfangioleiomiomatosi con la somministrazione di cellule muscolari lisce umane TSC2-/- 245
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival 242
Development of a LAM model by using human TSC2 deficient smooth muscle cells derived from a renal angiomylipoma 230
Proliferation and invasiveness of human smooth muscle TSC2-/- : Effect of anti-EGFR and rapamycin 226
Role of HMG-CoA reductase inhibitors in controlling TSC2-/- ASM cell growth and proliferation 224
Phenotype reversion of human TSC2-/- smooth muscle cells 223
An epigenetic event may underlies the TSC features in TSC2 ASM cells 217
Promoter methylation of TSC2 gene is important for pathogenesis of TSC and LAM lesions 217
PATHOGENESIS AND PHARMACOLOGY OF ISOLATED HUMAN TSC2 SMOOTH MUSCLE CELLS. NOVEL THERAPEUTIC PERSPECTIVES 217
Molecular characterization of growth and survival of human TSC2 gene-deficient smooth muscle-like cells 216
Anti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM 212
Reversion of the phenotype of human TSC2-/- smooth muscle cells 210
Isolation and growth characterization of two types of human TSC2 gene-deficient cells 201
Pharmacological and biochemical characterization of isolated and in vitro grown human TSC2 gene-deficient smooth muscle-like cells 191
Pharmacological reversion of the phenotype of human TSC2-/- smooth muscle cells 168
Totale 6.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021283 0 0 0 0 0 0 35 34 63 13 122 16
2021/2022472 73 28 29 19 30 13 43 11 75 44 16 91
2022/2023489 55 57 35 68 66 75 4 28 70 4 17 10
2023/2024319 12 19 18 26 80 42 3 29 12 14 26 38
2024/2025717 36 62 18 88 102 15 13 74 25 74 62 148
2025/2026991 181 93 205 124 138 108 142 0 0 0 0 0
Totale 6.647